mecamylamine has been researched along with Choroid Neovascularization in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiuchi, K | 1 |
| Matsuoka, M | 1 |
| Wu, JC | 1 |
| Lima e Silva, R | 1 |
| Kengatharan, M | 1 |
| Verghese, M | 1 |
| Ueno, S | 1 |
| Yokoi, K | 1 |
| Khu, NH | 1 |
| Cooke, JP | 1 |
| Campochiaro, PA | 1 |
1 other study available for mecamylamine and Choroid Neovascularization
| Article | Year |
|---|---|
Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.
Topics: Animals; Cells, Cultured; Choroid; Choroidal Neovascularization; Disease Models, Animal; Endothelium | 2008 |